KR880007070A - 백내장 치료용 약학 조성물 - Google Patents

백내장 치료용 약학 조성물

Info

Publication number
KR880007070A
KR880007070A KR1019870013736A KR870013736A KR880007070A KR 880007070 A KR880007070 A KR 880007070A KR 1019870013736 A KR1019870013736 A KR 1019870013736A KR 870013736 A KR870013736 A KR 870013736A KR 880007070 A KR880007070 A KR 880007070A
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
cataract
cataract treatment
treatment
compound
Prior art date
Application number
KR1019870013736A
Other languages
English (en)
Other versions
KR950007099B1 (ko
Inventor
신지 데라오
미쓰요시 아즈마
노리꼬 와따나베
Original Assignee
센쥬세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 센쥬세이야꾸 가부시끼가이샤 filed Critical 센쥬세이야꾸 가부시끼가이샤
Publication of KR880007070A publication Critical patent/KR880007070A/ko
Application granted granted Critical
Publication of KR950007099B1 publication Critical patent/KR950007099B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
KR1019870013736A 1986-12-03 1987-12-02 백내장 치료용 약학 조성물 KR950007099B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28807686 1986-12-03
JP288076/1986 1986-12-03

Publications (2)

Publication Number Publication Date
KR880007070A true KR880007070A (ko) 1988-08-26
KR950007099B1 KR950007099B1 (ko) 1995-06-30

Family

ID=17725491

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870013736A KR950007099B1 (ko) 1986-12-03 1987-12-02 백내장 치료용 약학 조성물

Country Status (8)

Country Link
US (1) US4826872A (ko)
EP (1) EP0270046B1 (ko)
KR (1) KR950007099B1 (ko)
CN (1) CN1016313B (ko)
AT (1) ATE110568T1 (ko)
CA (1) CA1300504C (ko)
DE (1) DE3750464T2 (ko)
ES (1) ES2059348T3 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871350A (en) * 1986-11-04 1989-10-03 Baylor College Of Medicine Methods and compositions for preventing secondary cataracts
US4966577A (en) * 1988-03-16 1990-10-30 Allergan, Inc. Prevention of lens-related tissue growth in the eye
US5627162A (en) * 1990-01-11 1997-05-06 Gwon; Arlene E. Methods and means for control of proliferation of remnant cells following surgery
US6046019A (en) * 1991-07-09 2000-04-04 Goumeniouk; Alexander P. Diagnostic kits and methods for making granulocyte cell counts
TW325997B (en) * 1993-02-02 1998-02-01 Senju Pharma Co Pharmaceutical composition for preventing and treating retinal diseases
KR20010052814A (ko) 1998-06-26 2001-06-25 오미야 히사시 치료제
PT1358883E (pt) * 2002-04-30 2007-10-01 Sifi Spa Composições farmacêuticas de re-epitelização contendo goma xantana
US20040229814A1 (en) * 2002-08-28 2004-11-18 James Dillon Methods and compositions for protecting against cataract development associated with vitrectomies
US20070166402A1 (en) * 2005-12-12 2007-07-19 Friedlaender Mitchell H Compositions, methods and kits for removing debris from an ocular area

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60130582A (ja) * 1983-12-19 1985-07-12 Takeda Chem Ind Ltd 食品用酸化防止剤，アスコルビン酸誘導体およびその製造法
EP0189272A3 (en) * 1985-01-17 1987-08-19 Fujisawa Pharmaceutical Co., Ltd. New furanone derivatives, processes for preparation thereof and use thereof
ZA852614B (en) * 1985-05-17 1986-10-09 Takeda Chemical Industries, Ltd. Ascorbic acid ethers and their production

Also Published As

Publication number Publication date
DE3750464T2 (de) 1995-02-09
EP0270046A2 (en) 1988-06-08
KR950007099B1 (ko) 1995-06-30
EP0270046B1 (en) 1994-08-31
CN1016313B (zh) 1992-04-22
ES2059348T3 (es) 1994-11-16
US4826872A (en) 1989-05-02
DE3750464D1 (de) 1994-10-06
ATE110568T1 (de) 1994-09-15
CA1300504C (en) 1992-05-12
EP0270046A3 (en) 1990-06-13
CN87107231A (zh) 1988-07-06

Similar Documents

Publication Publication Date Title
KR870700620A (ko) 신규 약리학적 화합물
ES2053587T3 (es) Nuevos derivados de bencimidazoles activos como agentes anti-ulcera.
ATE102930T1 (de) Heterozyklische verbindungen, deren herstellung und medikamente diese enthaltend.
IL84917A (en) Quinolinone derivative,its preparation and pharmaceutical compositions containing it
SE8404065D0 (sv) Novel biologically active compounds
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
KR880007070A (ko) 백내장 치료용 약학 조성물
SE8600658D0 (sv) Novel composition of matter
ATE62908T1 (de) Neue derivate von 4,5-dihydro-oxazolen, verfahren zu ihrer herstellung und ihre verwendung.
FI911138A0 (fi) Ny substituerad aminfoerening och foerfarande foer dess framstaellning.
DE3786865T2 (de) Aminosäurederivate enthaltende antikonvulsive Zusammensetzungen und Verwendung dieser Aminosäurederivate.
ATE38982T1 (de) Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel.
HUT54688A (en) Process for producing compounds utilizable for treating ulcus and pharmaceutical compositions containing them as active components
DE3884878D1 (de) Uricosuretische Zusammensetzung.
ATE101119T1 (de) Butensaeure-amide, deren salze, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung.
DE3784883T2 (de) Fluor enthaltende makrolid-verbindungen, pharmazeutische zusammensetzungen, welche diese enthalten und ihre verwendung fuer die herstellung von arzneimitteln.
DE3782229T2 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
PH22441A (en) Quinate salts of the antimaterial compound mefloquine

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19971226

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee